Full Text View
Tabular View
No Study Results Posted
Related Studies
Insulin Action: Role of Skeletal Muscle and Insulin-Mediated Blood Flow
This study has been completed.
Study NCT00018304   Information provided by Department of Veterans Affairs
First Received: July 3, 2001   Last Updated: January 20, 2009   History of Changes

July 3, 2001
January 20, 2009
 
 
 
 
Complete list of historical versions of study NCT00018304 on ClinicalTrials.gov Archive Site
 
 
 
Insulin Action: Role of Skeletal Muscle and Insulin-Mediated Blood Flow
Insulin Action: Role of Skeletal Muscle and Insulin-Mediated Blood Flow

The overall objective of this proposal is to examine the contribution of changes in total body fat, enhancement in insulin-mediated vasodilatation and enhancement in endothelium-derived nitric oxide production to the improvements in metabolic insulin action. In addition, the study will track whether these improvements are related to changes in blood pressure.

 
Phase I
Observational
 
Hypertension
 
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
 
 
 

Age 50 - 75 years, elevated blood pressure, BMI greater than 25 but less than 40 kg/m2

Both
50 Years to 75 Years
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00018304
 
AGCG-005-98S
Department of Veterans Affairs
 
Investigator: Arthur Leon, M.D.
Investigator: Alan Blank, M.D.
Department of Veterans Affairs
December 2004

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP